Enzo, Hologic, Grifols Settle Patent Dispute

Apr 22, 2019

|

NEW YORK (GenomeWeb) – Enzo Life Sciences has entered into a settlement and license agreement with Hologic, Grifols, and Grifols Diagnostic Solutions, Enzo disclosed in a recent filing with the US Securities and Exchange Commission.

The agreement settles all outstanding patent disputes among the parties and includes a one-time payment of $14 million to Enzo in exchange for fully paid-up, worldwide licenses to Hologic and Grifols, according to the SEC document.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Preprints During Lockdown

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

ApoE and COVID-19

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Search for Genetic Clues to COVID-19 Severity

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

Featured White Papers

NGS-Based Target Capture for SARS-CoV-2 Detection and Characterization

Best Practices for Point of Care (POC) Product Development

Seeing Beyond the Limit: Detect Residual Disease and Assess Treatment Response

A Personalized, Tumor-Informed Approach to Detect Molecular Residual Disease With High Sensitivity and Specificity

May

27

Featured Webinar

Identifying Molecular Drivers of Cancer via Comprehensive Sequencing of a Large Cohort with Matched Germline and Clinical Data

M2Gen’s Oncology Research Information Exchange Network (ORIEN) Avatar Research Program collects and studies consented cancer patients’ biospecimens and companion clinical information for the development of improved oncology treatments.

Jun

04

Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.

Menu

Enzo, Hologic, Grifols Settle Patent Dispute

To read the full story....

Breaking News

NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services

Colorectal Cancer Study Reveals Tumor Mutation, Immune Microenvironment Relationships

French Genetic Study Provides Insights Into Pre-Agriculture to Iron Age Populations

Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer

Top Five Articles on GenomeWeb Last Week: Roche, COVID-19, Clinico-Genomic Lung Cancer Study, and More

Alcohol Abuse Genetic Study Implicates Additional Variants in Risk of Problem Drinking

The Scan

Preprints During Lockdown

ApoE and COVID-19

Search for Genetic Clues to COVID-19 Severity

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

Featured White Papers

Identifying Molecular Drivers of Cancer via Comprehensive Sequencing of a Large Cohort with Matched Germline and Clinical Data

COVID-19 Testing, Treatment and Future Outlook

What's Popular?

NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

Exact Sciences, Express Gene, Avera Institute Get FDA EUAs for Coronavirus Tests

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Sponsorships